Anti-Human CD95 (APO-1/Fas) Purified

Also known as: CD95, Fas receptor, APT 1, ALPS 1 A, TNFRSF6

Clone: SM1/1

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# BMS138*

Cat. No. Size
BMS138 100 ug
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Description

Description: BMS138 is suitable as primary antibody in staining for FACS analysis.

Functional studies: BMS138 was found to induce apoptosis at 100 - 500 ng/ml in JURKAT cells and SKW6.4 cells if secondary crosslinking with anti-mouse IgG is used. Induces apoptosis in human Fas-transfectants without crosslinking.

Details
Host Mouse
Isotype lgG2a
Reactivity Human
Conjugate Purified
Reported Applications Flow Cytometric Analysis, Functional Assays
Documentation
TDS Link Download TDS
Related Products
References

Citations: Gajate,Consuelo; Mollinedo,Faustino. Cytoskeleton-mediated Death Receptor and Ligand Concentration in Lipid Rafts Forms Apoptosis-promoting Clusters in Cancer Chemotherapy. Journal of Biological Chemistry 2005;280:11641-11647. (Link)

Scotlandi,Katia; Baldini,Nicola; Cerisano,Vanessa; Manara,Maria Cristina; Benini,Stefania; Serra,Massimo; Lollini,Pier Luigi; Nanni,Patrizia; Nicoletti,Giordano; Bernard,Ghislaine; Bernard,Alain; Picci,Piero. CD99 Engagement: An Effective Therapeutic Strategy for Ewing Tumors. Cancer Research 2000;60:5134-5142. (Link)

Cabaner,Christelle; Gajate,Consuelo; Macho,Antonio; Munoz,Eduardo; Modolell,Manuel; Mollinedo,Faustino. Induction of apoptosis in human mitogen-activated peripheral blood T-lymphocytes by the ether phospholipid ET-18-OCH3: Involvement of the Fas receptor/ligand system. British Journal of Pharmacology 1999;127:813-825. (Link)

Mcgahon,Anne J.; Costa Pereira,Ana P.; Daly,Lisa; Cotter,Thomas G.. Chemotherapeutic drug-induced apoptosis in human leukaemic cells is independent of the Fas (APO-1/CD95) receptor/ligand system. British Journal of Haematology 1998;101:539-547. (Link)

Gajate,Consuelo; Mollinedo,Faustino. Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts. Blood 2006;109:blood-2006. (Link)

Gajate,Consuelo; Canto-Janez,Esther; Acuna,A.Ulises; Amat-Guerri,Francisco; Geijo,Emilio; Santos-Beneit,Antonio M.; Veldman,Robert J.; Mollinedo,Faustino. Intracellular Triggering of Fas Aggregation and Recruitment of Apoptotic Molecules into Fas-enriched Rafts in Selective Tumor Cell Apoptosis. Journal of Experimental Medicine 2004;200:353-365. (Link)

Fumarola C,A Zerbini and G G Guidotti. Glutamine deprivation-mediated cell shrinkage induces ligand-independent CD95 receptor signaling and apoptosis. Cell Death and Differentiation 2001;8:1004-1013. (Link)

Maeda,Hiroshi; Hori,Seiji; Nishitoh,Hideki; Ichijo,Hidenori; Ogawa,Osamu; Kakehi,Yoshiyuki; Kakizuka,Akira. Tumor Growth Inhibition by Arsenic Trioxide (As2O3) in the Orthotopic Metastasis Model of Androgen-independent Prostate Cancer. Cancer Research 2001;61:5432-5440. (Link)

Gajate,Consuelo; Mollinedo,Faustino. The antitumor ether lipid ET-18-OCH3 induces apoptosis through translocation and capping of Fas/CD95 into membrane rafts in human leukemic cells. Blood 2001;98:3860-3863. (Link)

O'Gorman,D.M.; McKenna,S.L.; McGahon,A.J.; Cotter,T.G.. Inhibition of PI3-kinase sensitises HL60 human leukaemia cells to both chemotherapeutic drug- and Fas-induced apoptosis... Leukemia Research 2001;25:801-811. (Link)

Sciorati,Clara; Rovere,Patrizia; Ferrarini,Marina; Paolucci,Clara; Heltai,Silvia; Vaiani,Roberto; Clementi,Emilio; Manfredi,Angelo A.. Generation of Nitric Oxide by the Inducible Nitric Oxide Synthase Protects {gamma}{delta} T Cells from Mycobacterium tuberculosis-Induced Apoptosis. The Journal of Immunology 1999;163:1570-1576. (Link)

Mahajan,Sandeep; Ghosh,Sutapa; Sudbeck,Elise A.; Zheng,Yaguo; Downs,Suzanne; Hupke,Michael; Uckun,Fatih M.. Rational Design and Synthesis of a Novel Anti-leukemic Agent Targeting Bruton's Tyrosine Kinase (BTK), LFM-A13 [alpha -Cyano-beta -Hydroxy-beta -Methyl-N-(2,5-Dibromophenyl)Propenamide]. Journal of Biological Chemistry 1999;274:9587-9599. (Link)

Vassilev,Alexei; Ozer,Zahide; Navara,Christopher; Mahajan,Sandeep; Uckun,Fatih M.. Bruton's Tyrosine Kinase as an Inhibitor of the Fas/CD95 Death-inducing Signaling Complex. Journal of Biological Chemistry 1999;274:1646-1656. (Link)

Nieto-Miguel,Teresa; Gajate,Consuelo; Mollinedo,Faustino. Differential Targets and Subcellular Localization of Antitumor Alkyl-lysophospholipid in Leukemic Versus Solid Tumor Cells. Journal of Biological Chemistry 2006;281:14833-14840. (Link)

Gajate,Consuelo; Gonzalez-Camacho,Fernando; Mollinedo,Faustino. Involvement of Raft Aggregates Enriched in Fas/CD95 Death-Inducing Signaling Complex in the Antileukemic Action of Edelfosine in Jurkat Cells. PLoS ONE 2009;4:(Link)

Wood,Carla M.; Goodman,Patricia A.; Vassilev,Alexei O.; Uckun,Fatih M.. CD95 (APO-1/FAS) deficiency in infant acute lymphoblastic leukemia: detection of novel soluble Fas splice variants. European Journal of Haematology 2003;70:156-171. (Link)